Description

Biktarvy – Complete HIV-1 Treatment Regimen (Rx)

Biktarvy is a fixed-dose combination antiretroviral medication used for the treatment of HIV-1 infection in adults and adolescents. It combines three active ingredients in a single tablet:

• Bictegravir – an integrase strand transfer inhibitor (INSTI)
• Emtricitabine – a nucleoside reverse transcriptase inhibitor (NRTI)
• Tenofovir alafenamide (TAF) – an NRTI

Together, these agents work by blocking HIV replication at multiple stages, helping to reduce viral load to undetectable levels and improve immune function (CD4 cell count).

buy Biktarvy with no prescription

We sell over-the-counter Biktarvy medicine; buy medicines with no prescription
livraison rapide, discrète et fiable
Paiement rapide et sécurisé
faire des achats en toute discrétion sans laisser de traces

Détails clés

• Active Ingredients: Bictegravir + Emtricitabine + Tenofovir alafenamide
• Drug Class: Combination antiretroviral therapy (INSTI + NRTIs)
• Indication: Treatment of HIV-1 infection
• Regimen Type: Complete once-daily single-tablet regimen
• Therapeutic Goal: Viral suppression and immune system support
• Statut de la prescription : Médicament délivré sur ordonnance

Cahier des charges

• Dosage Form: Film-coated oral tablet
• Strength (fixed-dose):
  • Bictegravir 50 mg
  • Emtricitabine 200 mg
  • Tenofovir alafenamide 25 mg
• Dosing Frequency: Once daily
• Administration: With or without food
• Onset of Action: Rapid viral load reduction over weeks
• Half-Life:
  • Bictegravir: ~17 hours
  • Emtricitabine: ~10 hours
  • TAF: intracellular activation with prolonged effect
• Metabolism:
  • Bictegravir: CYP3A4 and UGT1A1 pathways
• Excretion: Renal and fecal
• Conservation : température ambiante

Dosage et administration

• Standard dose: One tablet once daily
• Suitable for patients new to HIV treatment or switching from stable regimens
• Must be taken consistently at the same time each day

Compatibilité / Utilisation appropriée

• Adults and adolescents with HIV-1 infection
• Patients seeking a single-tablet complete regimen
• Individuals without known resistance to components
• Suitable for long-term therapy under specialist medical supervision

Why Choose Biktarvy?

Biktarvy offers a complete, once-daily HIV treatment in a single tablet, combining potency, convenience, and a high barrier to resistance. It is widely used as a first-line therapy due to its strong efficacy and tolerability profile.